Lupin Wins Tentative FDA Approval for COPD Inhalation Therapy Revefenacin
MUMBAI, India and NAPLES, Fla., May 18, 2026 Lupin Limited has announced that it has received tentative approval from...
Biosimilar Insulin
Advertisement
Sandoz Secures EC Approval for Bysumlog and Dazparda Diabetes Biosimilars
BASEL, Switzerland, May 15, 2026 Sandoz has announced that the European Commission (EC) granted marketing authorization for two biosimilar...
Lannett Secures FDA Nod for Interchangeable Insulin
PHILADELPHIA, May 4, 2026 Lannett Company, Inc., through its subsidiary Lanexa Biologics in partnership with Sunshine Lake Pharma, has...
Biocon Biologics Expands Insulin Glargine Access in U.S.
BRIDGEWATER, N.J., and BENGALURU, India – October 16, 2025: Biocon Biologics Ltd., a global leader in biosimilars, has expanded...
Advertisement
